Medical device company Globus Medical (NYSE:GMED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling ...

To properly understand Globus Medical's profit results, we need to consider the US$200m expense attributed to unusual items. While deductions due to unusual items are disappointing in the first ...

Globus Medical, Inc.’s GMED share price has dipped by 21.03%, which has investors questioning if this is right time to buy.

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...

Welcome to the Globus Medical’s First Quarter 2025 Earnings Call. [Operator Instructions]. I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and ...

In trading on Friday, shares of Globus Medical Inc (Symbol: GMED) entered into oversold territory, hitting an RSI reading of 23.1, after changing hands as low as $54.75 per share. By comparison ...

Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

For the quarter ended March 2025, Globus Medical (GMED) reported revenue of $598.12 million, down 1.4% over the same period last year. EPS came in at $0.68, compared to $0.72 in the year-ago quarter.

GMED opened at $55.54 on Friday. The business’s 50-day moving average price is $72.21 and its two-hundred day moving average price is $79.94. Globus Medical has a 1 year low of $54.48 and a 1 ...